Key publications
Key publications from Mohn Cancer Research Laboratory
Main content
- Nikolaienko, O., Eikesdal, H.P., Ognedal, E., Gilje, B., Lundgren, S., Blix, E.S., Espelid, H., Geisler, J., Geisler, S., Janssen, E.A.M., Yndestad, S., Minsaas, L., Leirvaag, B., Lillestøl, R., Knappskog, S. and Lønning, P.E. (2023). Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development. Genome Medicine, 15:104. https://doi.org/10.1186/s13073-023-01262-8
- Lønning, P.E., Nikolaienko, O., Pan, K., Kurian, A.W., Eikesdal, H.P., Pettinger, M., Anderson, G.L., Prentice, R.L., Chlebowski, R.T., Knappskog, S. (2022). Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer. JAMA Oncology, e223846. doi: 10.1001/jamaoncol.2022.3846.
- Venizelos, A., Engebrethsen, C., Deng, W., Geisler, J., Geisler, S., Iversen, G.T., Aas, T. Aase, H.S., Seyedzadeh, M., Steinskog, E.S., Myklebost, O., Nakken, S., Vodak, D., Hovig, E., Meza‑Zepeda, L.A., Lønning, P.E., Knappskog, S. and Eikesdal, H.P. (2022). Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy. Genome Medicine, 14:86. https://doi.org/10.1186/s13073-022-01090-2.
- Eikesdal, H.P., Yndestad, S., Elzawahry, A., Llop-Guevara, A., Gilje, B., Blix, E.S., Espelid, H., Lundgren, S., Geisler, J., Vagstad, G., Venizelos, A., Minsaas, L., Leirvaag, B., Gudlaugsson, E.G., Vintermyr, O.K., Aase, H.S., Aas, T., Balmaña, J., Serra, V., … Lønning, P. E. (2021). Olaparib monotherapy as primary treatment in unselected triple negative breast cancer. Annals of Oncology, 32(2), 240–249. https://doi.org/10.1016/j.annonc.2020.11.009
- Yates, L.R., Gerstung, M., Knappskog, S., Desmedt, C., Gundem, G., Van Loo, P., Aas, T., Alexandrov, L.B., Larsimont, D., Davies, H., Li, Y., Ju, Y.S., Ramakrishna, M., Haugland, H.K., Lilleng, P.K., Nik-Zainal, S., McLaren, S., Butler, A., Martin, S., Glodzik, D., Menzies, A., Raine, K., Hinton, J., Jones, D., Mudie, L.J., Jiang, B., Vincent, D., Greene-Colozzi, A., Adnet, P-Y., Fatima, A., Maetens, M., Ignatiadis, M., Stratton, M.R., Sotiriou, C., Richardson, A.L., Lønning, P.E., Wedge, D.C., and Campbell, P.J. (2015). Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nature Medicine. 21(7): 751-759.
- Sveen, A., Løes, I.M., Alagaratnam, S., Nilsen, G., Høland, M., Lingjærde, O.C., Sørbye, H., Berg, K.C.G., Horn, A., Angelsen, J-H., Knappskog, S., Lønning, P.E. and Lothe, R. (2016) Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection. PLoS Genetics. e1006225. doi: 10.1371/journal.pgen.1006225.
- Yates, L.R.*, Knappskog, S.*, Wedge, D.C, Farmery, J.H.R., Gonzalez, S., Martincorena, I., Alexandrov, L.B., Van Loo, P., Haugland, H.K., Lilleng, P.K., Gundem, G., Gerstung, M., Pappaemmanuil, E., Gazinska, P., Bhosle, S.G., Jones, D., Raine, K., Mudie, L., Latimer, C., Sawyer, E., Desmedt, C., Sotiriou, C., Stratton, M.R., Sieuwerts, A., Lynch, A.G., Martens, J.W., Richardson, A.L., Tutt, A., Lønning, P.E. and Campbell, P.J. (2017). Genomic evolution of breast cancer metastasis and relapse. Cancer Cell. 32: 169-184.
- Lønning, P.E., Berge, E.O., Bjørnslett, M., Minsaas, L., Chrisanthar, R., Høberg-Vetti, H., Dulary, C., Busato, F., Bjørneklett, S., Eriksen, C., Kopperud, R., Axcrona, U., Davidson, B., Bjørge, L., Evans, D.G., Howell, A., Salvesen, H.B., Janszky, I., Hveem, K., Romundstad, P., Vatten, L., Tost, J., Dørum, A. Knappskog, S. (2018). White blood cell BRCA1 promoter methylation status and ovarian cancer risk. Annals of Internal Medicine. 168(5): 326-334.
- Birkeland, E., Zhang, S., Poduval, D., Geisler, J., Nakken, S., Vodak, D., Meza-Zepeda, L.A., Hovig, E., Myklebost, O., Knappskog, S., Lønning, P.E. (2018). Patterns of genomic evolution in advanced melanoma. Nature Communications. 1-12. DOI:10.1038/s41467-018-05063-1.
19.12.2023